bcx 1812 has been researched along with 4-phenyl-4-oxo-2-hydroxybuten-2-oic acid in 1 studies
| Studies (bcx 1812) | Trials (bcx 1812) | Recent Studies (post-2010) (bcx 1812) | Studies (4-phenyl-4-oxo-2-hydroxybuten-2-oic acid) | Trials (4-phenyl-4-oxo-2-hydroxybuten-2-oic acid) | Recent Studies (post-2010) (4-phenyl-4-oxo-2-hydroxybuten-2-oic acid) |
|---|---|---|---|---|---|
| 25 | 1 | 12 | 12 | 0 | 2 |
| Protein | Taxonomy | bcx 1812 (IC50) | 4-phenyl-4-oxo-2-hydroxybuten-2-oic acid (IC50) |
|---|---|---|---|
| Genome polyprotein | Hepatitis C virus (isolate 1) | 5.7 | |
| RNA-directed RNA polymerase | 5.7 | ||
| Polymerase acidic protein | Influenza A virus (A/X-31(H3N2)) | 3.2 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Chou, KC; González-Díaz, H; Martinez de la Vega, O; Prado-Prado, FJ; Ubeira, FM; Uriarte, E | 1 |
1 other study(ies) available for bcx 1812 and 4-phenyl-4-oxo-2-hydroxybuten-2-oic acid
| Article | Year |
|---|---|
Unified QSAR approach to antimicrobials. 4. Multi-target QSAR modeling and comparative multi-distance study of the giant components of antiviral drug-drug complex networks.
Topics: Anti-Infective Agents; Antiviral Agents; Artificial Intelligence; Computer Simulation; Drug Evaluation, Preclinical; Molecular Structure; Quantitative Structure-Activity Relationship | 2009 |